busy making sauce
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
~QOIL .60 X .605 Chart...
Rig
~UGNE 2.33 X 2.34 Chart...
Like to see 2.50
~Rig
~QOIL .64 X .645 ~Rig
OT:Penny,
Yea I guess I should have asked my southern wife.lol.
~Rig
Excellent! let's get er done! ~Rig
~MLHP Sales News...
Millenia Hope Generates Second MMH Malarex(TM) Sale
New Contract to Also Generate Further Sales Over 12 Months
Aug 15, 2005 9:00:00 AM
MONTREAL, Aug. 15 /PRNewswire-FirstCall/ -- Millenia Hope Inc., a Delaware Biopharma corporation (OTC Bulletin Board: MLHP; Berlin: MLF), today announced that it has sold 10,000 treatments of MMH Malarex(TM)/MMH 18(TM) to a private clinic in Mali. This sale is the initial order from a second contract that could also generate sales of 100,000 treatments over the next 12 months.
Previously, on August 10, 2005, Millenia Hope announced its initial African sale of 25,000 treatments from a contract totaling 100,000 treatments spread over the following 12 months. Leonard Stella, CEO, stated, "It is very satisfying to know that we are part of the solution to such an insidious and devastating problem, the malaria plague. Millenia pledges its very best effort to help in curing this killer disease.
"There are 300-500 million malaria-infected individuals globally; three (3) million die annually, of which 1 million are children under five (5) years of age. An effective malaria cure is urgently needed. In many regions, 70% or more of malaria strains are resistant to existing medications and the World Health Organization (WHO) is no longer funding products like chloroquine to which malaria is resistant. MMH Malarex(TM)/MMH 18(TM) cures malaria in those regions where resistant strains are prevalent. MMH Malarex(TM) has cured nearly 1,000 malaria sufferers in its various trials over the last five (5) years. We are saving lives right now!"
About Millenia Hope
Millenia hope is in the business of developing innovative treatments and quality medication products that will lead to healthier lives. Our people are committed to research and development to deliver on medical needs globally and to bring hope through healthcare solutions.
Safe Harbor Statement
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, service offerings and markets.
For further information, please contact:
Mr. Hugo Valente
Tel: (514) 846-5757 or (514) 288-8822
Fax: (514) 935-9758
http://www.milleniahope.com
admin@milleniahope.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE Millenia Hope Inc.
----------------------------------------------
Mr. Hugo Valente of Millenia Hope
+1-514-846-5757 or +1-514-288-8822
Fax: +1-514-935-9758
admin@milleniahope.com
~CIRT News...
CirTran Reports 123% Increase in Sales and 11% Net Profit in 10Q Filing
Aug 15, 2005 7:30:00 AM
Copyright Business Wire 2005
SALT LAKE CITY--(BUSINESS WIRE)--Aug. 15, 2005--
CirTran Corporation (OTCBB:CIRT), an international full-service contract manufacturer of IT, consumer and consumer electronics products, has reported its first profitable quarter and the fifth consecutive quarter of growth and record sales in its 10-Q filing with the SEC for the period ended June 30, 2005.
Iehab J. Hawatmeh, founder and president of CirTran, said continued growth in domestic and off-shore business helped the company achieve an 11% net profit of $466,229, its first profitable quarter since becoming a public company in 2000. The 10-Q, he said, reported an $828,193 improvement over the loss of $361,964 for the same period in 2004.
CirTran was also profitable for the six months ended June 30, reporting $264,501, an improvement of $1,210,087 over the loss of $945,586 for the same period a year ago.
CirTran also achieved record sales for the fifth straight quarter, reporting revenues of $4,309,184, an increase of 123% over the $1,924,242 for the same period a year ago. Net sales for the six months was also a company-best with $7,229,649 reported, an increase of 277% over $2,603,604 for the first half of 2004.
In addition, CirTran's total assets more than doubled to $9,513,156 from $4,293,429 for the same period in 2004, with Total Shareholder Equity growing dramatically to $2,151,136 from ($2,242033) a year ago.
"On or Ahead of Strategic Plan"
Mr. Hawatmeh said that CirTran was "on or ahead of our strategic plan. This is the most exciting period of growth in the company's history, with our core business in Salt Lake City continuing to grow, attracting more and bigger customers, while our CirTran-Asia subsidiary in China has emerged as a player in manufacturing goods for the consumers and the sold-on-TV marketplace."
Mr. Hawatmeh said CirTran's record first half of 2005 followed a strong quarter for the company and an "overall fiscal revival in 2004."
About CirTran Corporation
Founded in 1993, CirTran Corporation (OTCBB:CIRT)(www.CirTran.com) is a premier international full-service contract manufacturer of low to mid size volume contracts for printed circuit board assemblies, cables and harnesses to the most exacting specifications. Headquartered in Salt Lake City, CirTran's modern 40,000-square foot non-captive manufacturing facility -- the largest in the Intermountain Region -- provides "just-in-time" inventory management techniques designed to minimize an OEM's investment in component inventories, personnel and related facilities, while reducing costs and ensuring speedy time-to-market.
About CirTran-Asia
CirTran-Asia (www.CirTran-Asia.com) was formed in 2004 as a high-volume manufacturing arm and wholly-owned subsidiary of CirTran Corporation with its principal office in ShenZhen, China. CirTran-Asia operates in three primary business segments: high-volume electronics, fitness equipment and household products manufacturing, focusing on being a leading manufacturer for the multi-billion dollar Direct Response Industry, which sells through infomercials, print and internet advertisements.
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.
Source: CirTran Corporation
----------------------------------------------
CirTran Corporation
Iehab J. Hawatmeh
801-963-5112
iehab@cirtran.com
or
The Kaminer Group
David A. Kaminer
914-684-1934 (Press)
dkaminer@kamgrp.com
~CRGO .021 X .022 News...
Cargo Connection Logistics Announces the Formation of New Division - Independent Transport Group, LLC; Revolutionary New Concept Designed to Attract Independent Contractors and Increase Size and Scope of Company's Driver Fleet
Aug 15, 2005 8:00:00 AM
Copyright Business Wire 2005
INWOOD, N.Y.--(BUSINESS WIRE)--Aug. 15, 2005--
Cargo Connection Logistics Holding, Inc. (OTCBB:CRGO) today announced it has created a subsidiary to be named Independent Transport Group, LLC (ITG).
ITG has been formed to attract current independent contractors and other carriers to perform work on behalf of Cargo Connection Logistics Corp. and Mid-Coast Management, Inc. The division has been formed to create a program specifically designed to assist the Company in increasing the size and scope of its driver fleet.
"We believe the creation of ITG is an innovative approach to creating an affinity and long-term relationship with the independent contractors who have been treated as outsiders within our industry," said Jesse Dobrinsky, CEO of Cargo Connection Logistics Holding, Inc. "Our ability to attract and retain drivers is critical to our success. The formation of ITG allows independent drivers the advantages of becoming an integral part of our organization and will still afford them the flexibility and independence they are accustomed to having, while at the same time securing some of critical benefits of being part of the Cargo Connection family."
ITG will be headed up by a team of seasoned executives with more than 40 years of combined experience in the Professional Employer Organization industry, including Ivan Dobrin who has more than 20 years of experience in the field. This team will allow ITG to create a culture and benefit structure that encourages independent drivers (owner operators) to enroll in the program. This in turn will provide Cargo Connection with a supply of drivers and additionally gives these drivers a reason to maintain their relationship with one company in an environment where drivers are scarce.
"Currently there is no incentive for independent drivers to stay with one company," added Dobrinsky. "Hopefully, this new program will give them the incentive, reason and the desire to join our team, which in turn, could vastly expand our fleet."
Cargo Connection Logistics Holding, Inc. consists of Cargo Connection Logistics Corp. and Mid-Coast Management Inc., which are both headquartered in Inwood, NY. The Companies also have offices in Atlanta, Charlotte, Chicago, Columbus, Miami, New York and Pittsburgh. The Companies provide a comprehensive variety of transportation and warehouse capacity services to shippers throughout the nation. Currently the two companies have 82 full-time employees.
About Cargo Connection Logistics Corp. / Mid-Coast Management, Inc.
Cargo Connection Logistics Corp. is a leader in world trade logistics. Headquartered adjacent to JFK International Airport, the company is a transportation logistics provider for shipments importing into and exporting out of the United States, especially through the Gateways of Chicago, Illinois; JFK, New York; Miami, Florida and Atlanta, Georgia with service areas throughout the United States and North America. Mid-Coast Management operates container freight station operations specifically designed to handle internationally arriving freight for companies like Mast Industries, the major supplier to Limited Brands - one of the world's largest multi-brand specialty retailers as well as many other significant fashion brands. Since its inception, Mid-Coast Management, Inc. has developed relationships with many other retailers and works with Freight Forwarders from around the world.
Additional information about Cargo Connection can be obtained at its website http://www.cargocon.com.
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the Company is detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Source: Cargo Connection Logistics Holding, Inc.
----------------------------------------------
For Cargo Connection Logistics Holding
Inc.
Inwood
Peter Nasca Associates
Inc.
Peter Nasca
305-937-1711
Email: pnasca@pnapr.com
~QOIL .50 X .51 News...
Quest Oil's Acadia North Wells 10-22 and 15-34 Hit Viking Gas Reservoir
Aug 15, 2005 6:00:00 AM
2005 PrimeZone Media Network
ARLINGTON, Texas, Aug. 15, 2005 (PRIMEZONE) -- Quest Oil Corporation (OTCBB:QOIL) is pleased to announce the successful drilling of Acadia North Prospect. Wells "10-22" and "15-34" were drilled through casing and into the Arneson Viking Gas pool. On August 8, 2005, using an endless tubing unit, wells "10-22" and "15-34" entered into the Viking zone and encountered commercial quantities of natural gas.
Arneson Well 10-22-25-2-W4M
"The well was open to flow, to a testing unit, on August 9 and flowed immediately at a stabilized rate of 0.3 MMCFPD and a flowing pressure of 900 psi. After flowing for 16 hours under these conditions, it was decided to test the well at higher rates. The well was opened up even more and after 7 hours flowed at a stabilized rate of 5 MMCFPD and a flowing pressure of 855 psi. The well was shut-in on August 10 to record a build up pressure. The bottom hole pressure gauges will be pulled in the middle of the week and it is expected that an AOF for this well will be available within four or five days," said Jim Deck; Production Manager, Transaction Oil and Gas Ventures Inc.
Quest Oil, President and CEO, Cameron King, states, "Well '10-22' establishes a benchmark well for Quest, the test data illustrates a sizeable well capable of producing at rates 10 times our anticipated flow of 0.5 MMCFPD. The Company is now waiting for all data to be retrieved and be interpreted to estimate gas reserve and life of the well."
Quest Oil, Project Advisor, Richard Johnson P.Eng. remarks, "The '10-22' well tested at rates of 5 million cubic feet per day (MMCFPD) at a high back pressure. This is a very strong well and should be held back to 1MMCFPD to 2 MMCFPD for engineering reasons until we fully understand the scope of this well and the zone. At current prices the well economic yield is $270,000 per month at 1MMCFPD and $540,000 when production is increased to 2MMcf/d. Well '10-22' by far is one of the best wells in the area."
Arneson Well 15-34-25-2-W4M
The well penetrated the Viking Sand on August 8 and is currently shut in due to lost equipment in the hole. Testing and data collection was suspended for well "15-34" due to a break in the endless tubing coil. At the time of drilling out of casing, the bottom-hole motor and bit were lost down hole. The Company has called in contractors to fish out the motor and continue with testing upon its removal. Prior to losing the motor, the well produced gas at measured rates exceeding 0.130 MMCFPD. "We did encounter high wellhead pressure measured during the drilling out process, this indicates the reservoir is not drained by production from offsetting wells and still contains significant gas reserves," said Richard Johnson, Project Engineer.
Quest Oil is considering implementing a 3D seismic program to fully understand the extent of the reserve throughout the Acadia valley. Based on the data received by the drill program, the reserve is significantly larger than expected and the Viking sand characteristics show sand thickening in areas. The company is also evaluating the economics of drilling two wells per section to drain the natural gas reserves to take advantage of the high commodity price.
ON BEHALF OF THE BOARD
Quest Oil Corporation.
To find out more about Quest Oil Corporation (OTCBB:QOIL), visit our website at www.questoil.com.
CONTACT: Quest Oil Corporation
Investor Information
Mr. Darren Hayes, Corporate Development
(866) 264-7668
~UGNE 1.93 X 1.94 FDA Approval News!...GM All!...
FDA Approves Fortical, Unigene's Nasal Calcitonin Product for Postmenopausal Osteoporosis; Unigene to Receive $4 Million Milestone Payment from Upsher-Smith
Aug 15, 2005 7:00:00 AM
Copyright Business Wire 2005
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 15, 2005--
Unigene Laboratories, Inc. (OTCBB:UGNE) has received approval from the U.S. Food and Drug Administration ("FDA") for Fortical(R) calcitonin-salmon (rDNA origin) Nasal Spray, its patented nasal calcitonin product for the treatment of postmenopausal osteoporosis. FDA approval triggers the final milestone payment of $4 million under Unigene's exclusive U.S. licensing agreement with Upsher-Smith Laboratories, Inc.
Fortical(R) will be manufactured at Unigene's production facility in Boonton, New Jersey. The final product will be packaged, marketed and sold in the United States by Upsher-Smith. Unigene will sell the filled product to Upsher-Smith and receive royalties on Upsher-Smith's sales.
"We are understandably excited to receive FDA approval for our first pharmaceutical product in the U.S.," commented Dr. Warren Levy, President and CEO of Unigene. "This is a pivotal accomplishment for any company in our industry and it will provide the rapidly growing population of postmenopausal osteoporosis sufferers with an additional option for managing the disease. We are confident that Upsher-Smith's enthusiasm and commitment to the product will give us the best opportunity to realize Fortical(R)'s potential. We expect that the revenues generated from sales of Fortical(R) will allow us to strengthen our financial position and expand our activities into new applications of our patented peptide manufacturing and oral delivery technologies."
"We are thrilled that the FDA has approved Unigene's Fortical(R) as an important therapy for the osteoporosis market, which in 2004 grew nearly 18% to reach $4 billion," said Mark Evenstad, Upsher-Smith President and Vice Chair. "We look forward to engaging our marketing and distribution expertise to help make this important calcitonin product available to the millions of Americans affected by osteoporosis."
Fortical(R) Indication
Fortical(R) is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass relative to healthy premenopausal women.
Conference Call Details
Unigene will host a conference call on August 15, 2005 beginning at 2:00 P.M. EDT to discuss the FDA approval of Fortical(R).
Unigene invites all those interested in hearing management's discussion of the FDA approval of Fortical to join the call by dialing 1-888-802-2266 for participants in the United States and 1-913-312-1270 for international participants and entering access code 4204125 when prompted. A replay will be available for 45 days after the call and can be accessed by dialing 1-888-203-1112 for participants in the United States and 1-719-457-0820 for international participants and entering access code 4204125 when prompted.
About Unigene
Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Unigene has licensed its oral PTH technology to GlaxoSmithKline. Unigene's patented oral delivery technology has successfully delivered, in preclinical and/or clinical trials, various peptides including calcitonin, PTH and insulin. Unigene's patented manufacturing technology is designed to cost-effectively produce peptides in quantities sufficient to support their worldwide commercialization as oral or nasal therapeutics. For more information about Unigene, call (973) 882-0860 or visit www.unigene.com.
About Upsher-Smith
Upsher-Smith Laboratories, Inc. is a fully integrated pharmaceutical company that manufactures and markets prescription pharmaceutical, OTC and cosmetic products. Upsher-Smith is also actively involved in licensing innovative compounds that are currently in clinical development. For more information about Upsher-Smith Laboratories, call (800) 654-2299 or visit www.upsher-smith.com.
Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements regarding us and our business, financial condition, results of operations and prospects. Such forward-looking statements include those which express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. We have based these forward-looking statements on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown which could cause actual results and developments to differ materially from those expressed or implied in such statements. These forward-looking statements include statements about the following: general economic and business conditions, our financial condition, competition, our dependence on other companies to commercialize, manufacture and sell products using our technologies, the uncertainty of results of animal and human testing, the risk of product liability and liability for human trials, our dependence on patents and other proprietary rights, dependence on key management officials, the availability and cost of capital, the availability of qualified personnel, changes in, or the failure to comply with, governmental regulations, the failure to obtain regulatory approvals for our products and other risk factors discussed in our Securities and Exchange Commission filings.. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "potential," "continue," and variations of these words (or negatives of these words) or similar expressions, are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors.
Source: Unigene Laboratories, Inc.
----------------------------------------------
The Investor Relations Group
Investors:
Damian McIntosh or Dian Griesel
Ph.D.
Media: Janet Vasquez
212-825-3210
or
Upsher-Smith Laboratories
Inc.
Phill Dritsas
763-315-2169
Have a great weekend all!! ~Rig
glassy, I said that twice already, one last time .lol.~Rig
~CRGO added .0195 ~Rig
LMAO!!!!!!!!!!!!!!! ~Rig
~CRGO ,I was filled more @ .0217 ~Rig
jonesie,
Just imagine what solid news could do.
~Rig
~GFCI .50 X .51 I'm in ,Charts...
~Rig
~RSVM 8.65 X 8.75 continues higher :)~Rig
~CRGO excellent volume, breaks 200 ma and the upper bollie if it gets through .03 ~Rig
Bought the dip ~Rig
~CRGO .0284 X .0285 .03 coming? Chart...
~Rig
mrgoodtrade/FURA,
I would like to see earnings come out soon.
~Rig
~CRGO Mentioned here , GM All~...
Stocks to Watch for Friday, August 12, 2005: EYII - EYI Industries Announces Letter of Intent Worth an Estimated US$210 Million!
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.
Aug 12, 2005 9:00:00 AM
ATLANTA, GA -- (MARKET WIRE) -- 08/12/05 -- Market Pulse is pleased to introduce our featured stock, EYI Industries Inc. (OTC BB: EYII), to the investment community! EYI Industries is new to Market Pulse and is poised to become a significant player in the wellness products industry! EYII just had excellent news out after Thursday's bell announcing that it has entered into a Letter of Intent worth an estimated US$210 Million! This could be big news for investors! Other notable stocks that should be watched because they look great from a fundamental and technical perspective include:
Dell Inc. (NASDAQ: DELL) : Market Underperform
Cargo Connection Logistics Holdings Inc. (OTC BB: CRGO) : Attractive
Cisco System Inc. (NASDAQ: CSCO) : Bearish
Recommendation Meanings
These recommendations are investment opinions of Market-Pulse.com and reflect the stock's potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.
After Thursday's Bell Market Commentary
On Thursday, first time applications for unemployment fell for the first time in three weeks by 6,000 to 308,000. Retail sales figures for July came in below expectations. The markets closed higher even as crude oil prices surged again to another record of $65.80 a barrel. The Dow Jones Industrial Average ended up 91.48 points, or 0.9%, at 10,685.89. The Nasdaq Composite Index ended up 16.74, or 0.8%, at 2,174.55. The S&P 500 Index ended up 8.68 points to close at 1,238. The Russell 2000 climbed 6 points to close at 666.
About Market-Pulse.com
Market Pulse LLC, the owner and operator of Market-Pulse.com (collectively referred to as "MP"), is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. MP is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. MP's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. MP provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. MP offers a free financial newsletter. To subscribe or get more information, visit our home page located at www.market-pulse.com.
Information contained herein is the opinion of MP and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: EYI Industries Inc. compensation from a third party shareholder: two million seven hundred fifty thousand free trading shares of stock in EYI Industries Inc., already delivered from a third party shareholder. To date, MP has sold zero shares of stock in EYI Industries Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services.
Contact:
Market Pulse
800.290.8935
Email Contact
shizzlesmack. I added more earlier today.Ready for your .30 again! ~Rig
Nice work Joe! ~Rig
tree,
nice to things turning positive!
~Rig
~RSVM 7.95 X 8.10 ~Rig
~CRGO .0246 X .025 HOD! ~Rig
.023 X .024
~SNPD .038 X .04 Accumulating here,chart...
North of .10 again IMO...
~Rig
Spark, added ETLC@ .11, last run was quite nice ~Rig
~MLHP .195X .20 Chart...
~Rig
~CRGO Chart...
~Rig
~CRGO looking good ~Rig
~MLHP .192 X .20 ~Rig
~MLHP .19 X .195 ~Rig
~AMBD .018 X .02 ~Rig
~QOIL Chart...
~Rig
~QOIL .53 X .55 Gapping :)~Rig
~GENM .003 X .0031 small gappage.GM All!~Rig